Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CONMED Corporation - Common Stock (NY:CNMD)

37.08 +0.52 (+1.42%)
Official Closing Price Updated: 4:10 PM EDT, Mar 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CONMED Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
1 Russell 2000 Stock on Our Buy List and 2 Facing Challenges
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size ... 
Via StockStory
Topics Economy
News headline image
3 Stocks Under $50 with Open Questions
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline... 
Via StockStory
News headline image
PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea... 
Via StockStory
Topics Economy
CONMED Corp (NYSE:CNMD) Posts Q4 Earnings Beat but Offers Cautious 2026 Outlook ↗
Via Chartmill
Topics Earnings
News headline image
1 Profitable Stock for Long-Term Investors and 2 We Ignore
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory
News headline image
3 Reasons CNMD is Risky and 1 Stock to Buy Instead
Over the past six months, CONMED’s shares (currently trading at $45.91) have posted a disappointing 15.7% loss, well below the S&P 500’s 7.2% gain. This was partly due to its softer quarterly results... 
Via StockStory
Topics Stocks Supply Chain
News headline image
5 Must-Read Analyst Questions From CONMED’s Q4 Earnings Call
CONMED’s fourth-quarter results were well received by the market, driven by standout performance in its orthopedics portfolio and continued progress in resolving supply chain challenges. Management... 
Via StockStory
Topics Earnings Economy
News headline image
1 Cash-Producing Stock to Target This Week and 2 We Find Risky
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
News headline image
CNMD Q4 Deep Dive: Ortho Outperformance and Strategic Refocusing Shape 2026 Outlook
Medical tech company CONMED (NYSE:CNMD) announced better-than-expected revenue in Q4 CY2025, with sales up 7.9% year on year to $373.2 million. On the other hand, the company’s full-year revenue... 
Via StockStory
Topics Economy World Trade
News headline image
CONMED (CNMD) Q4 2025 Earnings Call Transcript ↗
CONMED (CNMD) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings Economy
News headline image
CONMED (NYSE:CNMD) Beats Q4 CY2025 Sales Expectations, Stock Soars
Medical tech company CONMED (NYSE:CNMD) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 7.9% year on year to $373.2 million. On the other hand, the company’s... 
Via StockStory
News headline image
CONMED Corporation Announces Fourth Quarter and Full-Year 2025 Financial Results
From CONMED Corporation
Via Business Wire
News headline image
CONMED Earnings: What To Look For From CNMD
Medical tech company CONMED (NYSE:CNMD) will be announcing earnings results this Wednesday after market close. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
News headline image
Surgical Equipment & Consumables - Diversified Stocks Q3 Results: Benchmarking CONMED (NYSE:CNMD)
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including CONMED (NYSE:CNMD) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
3 Reasons to Sell CNMD and 1 Stock to Buy Instead
Over the past six months, CONMED’s stock price fell to $43.42. Shareholders have lost 13.3% of their capital, which is disappointing considering the S&P 500 has climbed by 11.1%. This may have... 
Via StockStory
Topics Stocks Supply Chain
News headline image
3 Reasons to Avoid CNMD and 1 Stock to Buy Instead
What a brutal six months it’s been for CONMED. The stock has dropped 20.6% and now trades at $42.52, rattling many shareholders. This may have investors wondering how to approach the situation. 
Via StockStory
Topics Supply Chain
News headline image
CONMED Corporation Announces Chief Financial Officer Transition
From CONMED Corporation
Via Business Wire
News headline image
CONMED Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference
From CONMED Corporation
Via Business Wire
News headline image
CONMED Corporation to Announce Fourth Quarter 2025 Financial Results on January 28, 2026
From CONMED Corporation
Via Business Wire
News headline image
1 Safe-and-Steady Stock on Our Watchlist and 2 We Avoid
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
Via StockStory
News headline image
Why CONMED (CNMD) Stock Is Trading Up Today
Shares of medical tech company CONMED (NYSE:CNMD) jumped 3.3% in the afternoon session after positive sentiment in the medical device sector was buoyed by the highly successful initial public offering... 
Via StockStory
Topics Initial Public Offering
News headline image
3 Russell 2000 Stocks That Concern Us
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher... 
Via StockStory
News headline image
Why CONMED (CNMD) Shares Are Plunging Today
Shares of medical tech company CONMED (NYSE:CNMD) fell 6.2% in the morning session after the company announced its plan to exit its gastroenterology product lines as part of a broader portfolio... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
CONMED Corporation Announces Strategic Exit from Gastroenterology Product Lines
From CONMED Corporation
Via Business Wire
News headline image
3 Value Stocks We’re Skeptical Of
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued... 
Via StockStory
News headline image
3 of Wall Street’s Favorite Stocks We Think Twice About
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because... 
Via StockStory
News headline image
3 Healthcare Stocks We Steer Clear Of
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong financial performance but... 
Via StockStory
Topics Stocks
News headline image
CONMED, Select Medical, BrightSpring Health Services, Privia Health, and RadNet Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated... 
Via StockStory
Topics Economy
News headline image
1 Cash-Producing Stock Worth Your Attention and 2 We Turn Down
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
Topics Economy
News headline image
5 Insightful Analyst Questions From CONMED’s Q3 Earnings Call
CONMED’s third quarter results were marked by steady revenue growth in both orthopedics and general surgery, supported by continued surgeon adoption of core products like BioBrace and the AirSeal... 
Via StockStory
Topics Earnings Economy World Trade
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.